Svelte Medical Systems is Surgical Devices in United States that focus on eluting coronary stent business. Founded in 2007. They cover business area such as developer, a-wire, (IDS, coronary artery disease, specialized ASAHI guide wire tip technology, its proprietary balloon, direct stenting, a guide-wire, additional guide wire, most case, patient, well clinical outcome, enhance comfort, reduce time, cost, procedure.
2007
( 17 years old in 2024 )
Eluting Coronary Stent
-
675 Central Avenue
New Providence, NJ 07974
United States
Private
developera-wire(IDScoronary artery diseasespecialized ASAHI guide wire tip technologyits proprietary balloondirect stentinga guide-wireadditional guide wiremost casepatientwell clinical outcomeenhance comfortreduce timecostprocedure
* We use standard office opening hours in near Svelte Medical Systems's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Svelte Medical Systems is Surgical Devices business from United States that founded in 2007 (17 years old in 2024), Svelte Medical Systems business is focusing on Eluting Coronary Stent.
Svelte Medical Systems headquarter office and corporate office address is located in 675 Central Avenue New Providence, NJ 07974 United States.
Svelte Medical Systems was founded in United States.
In 2024, Svelte Medical Systems is currently focus on eluting coronary stent sector.
Above is snippet of Google Trends for "eluting coronary stent" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Svelte Medical Systems, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.